Dodge & Cox Neurocrine Biosciences Inc Transaction History
Dodge & Cox
- $164 Billion
- Q1 2025
A detailed history of Dodge & Cox transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Dodge & Cox holds 5,534,624 shares of NBIX stock, worth $735 Million. This represents 0.37% of its overall portfolio holdings.
Number of Shares
5,534,624
Previous 3,016,425
83.48%
Holding current value
$735 Million
Previous $412 Million
48.67%
% of portfolio
0.37%
Previous 0.26%
Shares
7 transactions
Others Institutions Holding NBIX
# of Institutions
648Shares Held
96.9MCall Options Held
749KPut Options Held
553K-
Black Rock Inc. New York, NY14.2MShares$1.88 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.32 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.86MShares$645 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$355 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.5MShares$332 Million0.44% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12.7B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...